---
layout: default
title: Oteracil
description: "Oteracil 的老藥新用潛力分析。高證據等級 L2，包含 10 個預測適應症。查看 AI 預測與臨床證據完整報告。"
parent: 高證據等級 (L1-L2)
nav_order: 118
evidence_level: L1
indication_count: 10
---

# Oteracil

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
證據等級: <strong>L2</strong> | 預測適應症: <strong>10</strong> 個
</p>

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Oteracil：從胃癌到大腸腫瘤

## 一句話總結

<p class="key-answer" data-question="Oteracil 可以用於治療什麼新適應症？">
Oteracil 是 S-1 複方的成分之一，原本用於胃癌治療。
TxGNN 模型預測它可能對**大腸腫瘤 (Colonic Neoplasm)** 有效，
目前有 **7 個臨床試驗**和 **10 篇文獻**支持這個方向。
</p>


## 快速總覽

| 項目 | 內容 |
|------|------|
| 原適應症 | 胃癌用藥。 |
| 預測新適應症 | colonic neoplasm、cecum villous adenoma、cecum neuroendocrine tumor G1、lipoma of colon、cecal disease、rectosigmoid junction neoplasm、benign neoplasm of cecum、colonic lymphangioma、colon leiomyoma、cavernous hemangioma of colon |
| TxGNN 預測分數 | 99.99% |
| 證據等級 | L2 |
| 台灣上市 | ✓ 已上市 |
| 許可證數 | 8 張 |
| 建議決策 | Proceed with Guardrails |






## 預測適應症詳細分析

<details class="indication-section" open>
<summary>
<span class="indication-name">1. colonic neoplasm</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.99%</span> <span class="primary-badge">主要分析</span>
</summary>
<div class="indication-content">

<h3>為什麼這個預測合理？</h3>

<p><p class="key-answer" data-question="這個藥物的作用機轉是什麼？"></p>
<p>目前缺乏詳細的作用機轉資料。根據已知資訊，Oteracil 是 S-1 複方的一部分，其成分在胃癌中的療效已被證實，機轉上可能適用於大腸腫瘤。S-1 包含的 tegafur 是 5-FU 的前驅藥，已知能夠抑制快速分裂的癌細胞中的 DNA 合成，這在大腸腫瘤中可能有效。</p>
<p></p></p>

<p><div class="key-takeaway"></p>
<p>此預測基於藥物的作用機轉，與現有臨床證據方向一致。</p>

<h3>臨床試驗</h3>

<table>
<thead>
<tr><th>試驗編號</th><th>階段</th><th>狀態</th><th>人數</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00524706" target="_blank">NCT00524706</a></td><td>PHASE1, PHASE2</td><td>UNKNOWN</td><td>42</td><td>Phase I/II Study of S-1, Oral Leucovorin, and Oxaliplatin Combination Therapy (S...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02618356" target="_blank">NCT02618356</a></td><td>PHASE2</td><td>UNKNOWN</td><td>82</td><td>A Phase II Clinical Study of Combined Use of Raltitrexed and S-1 as Treatment fo...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00974389" target="_blank">NCT00974389</a></td><td>PHASE2</td><td>UNKNOWN</td><td>40</td><td>Phase II Study of Combination Chemotherapy With S-1 Plus Avastin in Unresectable...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01918852" target="_blank">NCT01918852</a></td><td>PHASE3</td><td>COMPLETED</td><td>161</td><td>S1 Versus Capecitabine in the First Line Treatment of Metastatic Colorectal Canc...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03448549" target="_blank">NCT03448549</a></td><td>PHASE3</td><td>UNKNOWN</td><td>1191</td><td>A Prospective Randomized Controlled Trial to Compare Oxaliplatin Combined With S...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06255379" target="_blank">NCT06255379</a></td><td>PHASE2</td><td>NOT_YET_RECRUITING</td><td>52</td><td>An Open, Single-arm, Multicenter, Prospective Phase II Study of Fuquinitinib Com...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00660894" target="_blank">NCT00660894</a></td><td>PHASE3</td><td>COMPLETED</td><td>1535</td><td>Randomized Phase III Study of UFT+Leucovorin vs. TS-1 as Adjuvant Treatment for ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02216149" target="_blank">NCT02216149</a></td><td>PHASE2</td><td>TERMINATED</td><td>20</td><td>Effects of S-1 and Capecitabine in Combination With Oxaliplatin on the Coronary ...</td></tr>
</tbody>
</table>

<h3>相關文獻</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25209093/" target="_blank">25209093</a></td><td>2014</td><td>Article</td><td>Clinical colorectal cancer</td><td>Adaptation of international guidelines for metastatic colorectal cancer: an asia...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28414195/" target="_blank">28414195</a></td><td>2017</td><td>Article</td><td>European journal of dermatolog</td><td>Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/20500514/" target="_blank">20500514</a></td><td>2010</td><td>Article</td><td>Cancer science</td><td>Characterization of a novel lymph node metastasis model from human colonic cance...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32936722/" target="_blank">32936722</a></td><td>2021</td><td>Article</td><td>Journal of oncology pharmacy p</td><td>Hypertriglyceridemia induced by S-1: A novel case report and review of the liter...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26805106/" target="_blank">26805106</a></td><td>2015</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[A Successful Case of Treatment of Colonic Metastasis and Peritoneal Recurrence ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/17496461/" target="_blank">17496461</a></td><td>2007</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[Adjuvant chemotherapy for colorectal cancer in Japan-current state and problem ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31917122/" target="_blank">31917122</a></td><td>2020</td><td>Article</td><td>Clinical colorectal cancer</td><td>S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuva...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/29491068/" target="_blank">29491068</a></td><td>2018</td><td>Article</td><td>Anticancer research</td><td>Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced i...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26976971/" target="_blank">26976971</a></td><td>2016</td><td>Article</td><td>Anticancer research</td><td>Genome-wide DNA Copy-number Analysis in ACTS-CC Trial of Adjuvant Chemotherapy f...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12833857/" target="_blank">12833857</a></td><td>2003</td><td>Article</td><td>Nihon Shokakibyo Gakkai zasshi</td><td>[Recent advances in chemotherapy for digestive cancers with special references t...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25132036/" target="_blank">25132036</a></td><td>2014</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[A case of disseminated carcinomatosis of the bone marrow with disseminated intr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/27056996/" target="_blank">27056996</a></td><td>2016</td><td>Article</td><td>Annals of oncology : official </td><td>A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy f...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/40840913/" target="_blank">40840913</a></td><td>2025</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[A Case of Long-Term Complete Remission with Solitary Metastasis Following Surge...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26036466/" target="_blank">26036466</a></td><td>2015</td><td>Article</td><td>BMC cancer</td><td>Randomized phase II study of S-1 dosing schedule for resected colorectal cancer.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32189156/" target="_blank">32189156</a></td><td>2020</td><td>Article</td><td>International journal of clini</td><td>Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for treating patients w...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24942277/" target="_blank">24942277</a></td><td>2014</td><td>Article</td><td>Annals of oncology : official </td><td>S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23320901/" target="_blank">23320901</a></td><td>2013</td><td>Article</td><td>Trials</td><td>Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: s...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/21875473/" target="_blank">21875473</a></td><td>2011</td><td>Article</td><td>Zhonghua zhong liu za zhi [Chi</td><td>[Efficacy and side effects of combination therapy of oxaliplatin and S-1 for col...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10897209/" target="_blank">10897209</a></td><td>2000</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26045119/" target="_blank">26045119</a></td><td>2015</td><td>Article</td><td>Tumori</td><td>Long-term survival in metastasized leiomyosarcoma: a case report and review of t...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. cecum villous adenoma</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. cecum neuroendocrine tumor G1</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. lipoma of colon</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. cecal disease</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（9 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39024793/" target="_blank">39024793</a></td><td>2024</td><td>Article</td><td>Journal of pharmaceutical and </td><td>Amelioration of hyperuricemia by cordycepin and Cordyceps militaris aqueous extr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25918266/" target="_blank">25918266</a></td><td>2015</td><td>Article</td><td>Hinyokika kiyo. Acta urologica</td><td>[Vesico-appendiceal fistula caused by appendiceal cancer: a case report].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22333648/" target="_blank">22333648</a></td><td>2012</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[A case of cecal cancer with abdominal wall abscess].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/30692384/" target="_blank">30692384</a></td><td>2018</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[A Case of Complete Response to Computed Tomography-Guided Celiac Plexus Neuroly...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24018598/" target="_blank">24018598</a></td><td>2013</td><td>Article</td><td>JOP : Journal of the pancreas</td><td>Synchronous triple cancers of the pancreas, stomach, and cecum treated with S-1 ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/17431353/" target="_blank">17431353</a></td><td>2007</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[Successful low-dose TS-1 administration in an elderly colon cancer patient with...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16612166/" target="_blank">16612166</a></td><td>2006</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[A case of advanced colon cancer with metastases to both para-aortic lymph nodes...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/29362308/" target="_blank">29362308</a></td><td>2018</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[An Elderly Patient with Metastatic Colon Cancer Achieved Long-Term Survival Fol...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24189822/" target="_blank">24189822</a></td><td>2013</td><td>Article</td><td>Nihon Shokakibyo Gakkai zasshi</td><td>[A case of advanced signet ring cell carcinoma of the appendix that responded to...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. rectosigmoid junction neoplasm</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. benign neoplasm of cecum</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（6 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10997934/" target="_blank">10997934</a></td><td>2000</td><td>Article</td><td>Drug metabolism and dispositio</td><td>Tissue distribution and biotransformation of potassium oxonate after oral admini...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24018598/" target="_blank">24018598</a></td><td>2013</td><td>Article</td><td>JOP : Journal of the pancreas</td><td>Synchronous triple cancers of the pancreas, stomach, and cecum treated with S-1 ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22202431/" target="_blank">22202431</a></td><td>2011</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[A long-term survival case in advanced mucinous cystadenocarcinoma of the append...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22333648/" target="_blank">22333648</a></td><td>2012</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[A case of cecal cancer with abdominal wall abscess].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26199249/" target="_blank">26199249</a></td><td>2015</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[Clinical Response of Metastatic Colon Cancer to Chemotherapy with S-1 and Oxali...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/17431353/" target="_blank">17431353</a></td><td>2007</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[Successful low-dose TS-1 administration in an elderly colon cancer patient with...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. colonic lymphangioma</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. colon leiomyoma</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<h3>相關文獻（1 篇）</h3>

<table>
<thead>
<tr><th>PMID</th><th>年份</th><th>類型</th><th>期刊</th><th>主要發現</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/40322391/" target="_blank">40322391</a></td><td>2025</td><td>Article</td><td>Cureus</td><td>Torsion of Metastatic Ovarian Tumor Originating From Sigmoid Colon Cancer.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. cavernous hemangioma of colon</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果，需進一步驗證。
</div>

</div>
</details>


## 台灣上市資訊

| 許可證號 | 品名 | 劑型 | 核准適應症 |
|---------|------|------|-----------|
| 衛部藥製字第061956號 | "杏輝"氮尿嘧啶酸鉀鹽 | （粉） | 胃癌用藥。 |
| 衛部藥製字第058552號 | "台耀"歐特拉西兒 | 粉劑 | 胃癌用藥。 |
| 衛署藥輸字第025243號 | 愛斯萬膠囊20毫克 | 膠囊劑 | 胃癌、胰臟癌、大腸直腸癌、非小細胞肺癌、膽道癌、早期乳癌 |

## 細胞毒性

| 項目 | 內容 |
|------|------|
| 細胞毒性分類 | 傳統細胞毒性藥物（Fluoropyrimidine 類） |
| 骨髓抑制風險 | 中度 |
| 致吐性分級 | 低至中度 |
| 監測項目 | CBC（含分類）、肝腎功能、電解質 |
| 處置防護 | 需依細胞毒性藥物處置規範操作 |

## 安全性考量

安全性資訊請參考原廠仿單。

## 結論與下一步

**決策：Proceed with Guardrails**

**理由：**
有多個 Phase 2/3 臨床試驗支持 S-1 用於結直腸癌的療效，且 S-1 複方已在台灣取得大腸直腸癌適應症，證據充分。

**若要推進需要：**
- 詳細的藥物作用機轉資料（MOA）
- 特定族群的安全性監測計畫


---

## 相關藥物報告

- [Prednisone]({{ "/drugs/prednisone/" | relative_url }}) - 證據等級 L2
- [Regorafenib]({{ "/drugs/regorafenib/" | relative_url }}) - 證據等級 L2
- [Isosorbide Dinitrate]({{ "/drugs/isosorbide_dinitrate/" | relative_url }}) - 證據等級 L2
- [Dronedarone]({{ "/drugs/dronedarone/" | relative_url }}) - 證據等級 L2
- [Carboplatin]({{ "/drugs/carboplatin/" | relative_url }}) - 證據等級 L2

---

{% include ai-analysis.html %}

{% include social-share.html %}

## 引用本報告

如需引用本報告，請使用以下格式：

**APA 格式：**
```
TwTxGNN. (2026). Oteracil老藥新用驗證報告. https://twtxgnn.yao.care/drugs/oteracil/
```

**BibTeX 格式：**
```bibtex
@misc{twtxgnn_oteracil,
  title = {Oteracil老藥新用驗證報告},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/oteracil/}
}
```

---

<div class="disclaimer">
<strong>免責聲明</strong><br>
本報告僅供學術研究參考，<strong>不構成醫療建議</strong>。藥物使用請遵循醫師指示，切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。
<br><br>
<small>最後審核：2026-02-20 | 審核者：TwTxGNN Research Team</small>
</div>

{% include giscus.html %}
